247 related articles for article (PubMed ID: 32824919)
1. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
Dye BK; Butler C; Lincoln J
J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome.
Gonzalez BA; Harmeyer SW; Song T; Sadayappan S; Yutzey KE
Matrix Biol; 2024 Feb; 126():1-13. PubMed ID: 38185344
[TBL] [Abstract][Full Text] [Related]
4. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
[TBL] [Abstract][Full Text] [Related]
5. The pathomechanism of human myxomatous valvular degeneration at the mechanical and cellular level.
Hu C; Wang Q; Xue H; Hong H; Shi J; Dong N; Zhang M
Rev Cardiovasc Med; 2021 Jun; 22(2):513-519. PubMed ID: 34258920
[TBL] [Abstract][Full Text] [Related]
6. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
Xu N; Alfieri CM; Yu Y; Guo M; Yutzey KE
Arterioscler Thromb Vasc Biol; 2024 Apr; ():. PubMed ID: 38660802
[TBL] [Abstract][Full Text] [Related]
7. Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).
Han RI; Clark CH; Black A; French A; Culshaw GJ; Kempson SA; Corcoran BM
Vet J; 2013 Aug; 197(2):388-94. PubMed ID: 23465752
[TBL] [Abstract][Full Text] [Related]
8. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis.
Merryman WD; Youn I; Lukoff HD; Krueger PM; Guilak F; Hopkins RA; Sacks MS
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H224-31. PubMed ID: 16126816
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
[TBL] [Abstract][Full Text] [Related]
10. On intrinsic stress fiber contractile forces in semilunar heart valve interstitial cells using a continuum mixture model.
Sakamoto Y; Buchanan RM; Sacks MS
J Mech Behav Biomed Mater; 2016 Feb; 54():244-58. PubMed ID: 26476967
[TBL] [Abstract][Full Text] [Related]
11. Defining the Role of the miR-145-KLF4-αSMA Axis in Mitral Valvular Interstitial Cell Activation in Myxomatous Mitral Valve Prolapse Using the Canine Model.
Yang VK; Moyer N; Zhou R; Carnevale SZ; Meola DM; Robinson SR; Li G; Das S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338749
[TBL] [Abstract][Full Text] [Related]
12. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.
Rabkin E; Aikawa M; Stone JR; Fukumoto Y; Libby P; Schoen FJ
Circulation; 2001 Nov; 104(21):2525-32. PubMed ID: 11714645
[TBL] [Abstract][Full Text] [Related]
13. Development and Evaluation of a Tissue-Engineered Fibrin-based Canine Mitral Valve Three-dimensional Cell Culture System.
Liu MM; Flanagan TC; Jockenhovel S; Black A; Lu CC; French AT; Argyle DJ; Corcoran BM
J Comp Pathol; 2018 Apr; 160():23-33. PubMed ID: 29729718
[TBL] [Abstract][Full Text] [Related]
14. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.
Shapero K; Wylie-Sears J; Levine RA; Mayer JE; Bischoff J
J Mol Cell Cardiol; 2015 Mar; 80():175-85. PubMed ID: 25633835
[TBL] [Abstract][Full Text] [Related]
17. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.
Mahimkar R; Nguyen A; Mann M; Yeh CC; Zhu BQ; Karliner JS; Lovett DH
Cardiovasc Pathol; 2009; 18(5):253-61. PubMed ID: 18835790
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse.
Rizzo S; Basso C; Lazzarini E; Celeghin R; Paolin A; Gerosa G; Valente M; Thiene G; Pilichou K
Cardiovasc Pathol; 2015; 24(6):359-67. PubMed ID: 26345253
[TBL] [Abstract][Full Text] [Related]
19. Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.
Barnette DN; Hulin A; Ahmed AS; Colige AC; Azhar M; Lincoln J
J Mol Cell Cardiol; 2013 Dec; 65():137-46. PubMed ID: 24157418
[TBL] [Abstract][Full Text] [Related]
20. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.
Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G
Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
